Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health-Reference-Cited by-同舟云学术

Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health

Published:2024-02-22 Issue:1 Volume:15 Page:134-141
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

De Matteis Elisabetta¹,Tumolo Maria Rosaria²,Tarantino Paolo³,Ciccarese Mariangela⁴,Grassi Tiziana²,Bagordo Francesco⁵,De Giorgio Maria Rita¹,Rizzo Emanuele²,Ronzino Graziana⁶

Affiliation:

1. U.O.S.V.D. Oncological Screenings, “Vito Fazzi” Hospital, Lecce, Italy

2. Department of Biological and Environmental Sciences and Technology, University of Salento, Lecce, Italy

3. U.O.C. Medical Genetics, “Vito Fazzi” Hospital, Lecce, Italy

4. Strategic Regional Agency for Health and Social of Puglia, Bari, Italy

5. Department of Pharmacy-Pharmaceutical Sciences, University of Bari “Aldo Moro”, Bari, Italy

6. Oncology Unit, “Vito Fazzi” Hospital, Lecce, Italy

Publisher

Impact Journals, LLC

Reference39 articles.

1. Ovarian cancer in the world: epidemiology and risk factors;Salehiniya;Int J Womens Health,2019

2. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial;Manchanda;Lancet,2021

3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Bray;CA Cancer J Clin,2021

4. I numeri del cancro in Italia, 2022. AIOM-Registri Tumori Italiani-SIAPEC-PASSI-PASSI D’ARGENTO-ONS-Fondazione AIOM.

5. Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21);Spagnoletti;Gynecol Oncol,2021